رويفانت ساينسز المحدودة
US ˙ NasdaqGS ˙ BMG762791017

SecurityROIV / Roivant Sciences Ltd.
InsiderVivek Ramaswamy
This page shows the track record and history of Ramaswamy Vivek insider trades in Roivant Sciences Ltd.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Vivek Ramaswamy in ROIV / Roivant Sciences Ltd.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ROIV / Roivant Sciences Ltd. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Vivek Ramaswamy in ROIV / Roivant Sciences Ltd.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-09-05 385,816 12.9600 385,816 12.9600 5,000,175 0 12.9100 -19,290 -0.39
2025-09-04 194,933 12.9200 194,933 12.9200 2,518,534
2025-09-03 1,195,000 12.5000 1,195,000 12.5000 14,937,500
2025-06-20 577,007 11.4600 577,007 11.4600 6,612,500
2025-06-18 565,266 11.4500 565,266 11.4500 6,472,296
2025-06-06 200,800 11.1900 200,800 11.1900 2,246,952
2025-06-04 547,430 11.3400 547,430 11.3400 6,207,856
2025-05-07 625,000 11.1800 625,000 11.1800 6,987,500
2025-05-06 273,959 11.4700 273,959 11.4700 3,142,310
2024-01-02 3,000,000 11.0500 3,000,000 11.0500 33,150,000
2023-02-22 4,000,000 7.9500 4,000,000 7.9500 31,800,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ROIV / Roivant Sciences Ltd. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-05 2025-09-05 4 Ramaswamy Vivek ROIV Common Shares S - Sale D 12.9600 -385,816 -5,000 35,508,359
2025-09-05 2025-09-04 4 Ramaswamy Vivek ROIV Common Shares S - Sale D 12.9200 -194,933 -2,519 35,894,175
2025-09-05 2025-09-03 4 Ramaswamy Vivek ROIV Common Shares S - Sale D 12.5000 -1,195,000 -14,938 36,089,108
2025-06-23 2025-06-20 4 Ramaswamy Vivek ROIV Common Shares S - Sale D 11.4600 -577,007 -6,613 37,284,108
2025-06-23 2025-06-18 4 Ramaswamy Vivek ROIV Common Shares S - Sale D 11.4500 -565,266 -6,472 37,861,115
2025-06-06 2025-06-06 4 Ramaswamy Vivek ROIV Common Shares S - Sale D 11.1900 -200,800 -2,247 38,426,381
2025-06-06 2025-06-04 4 Ramaswamy Vivek ROIV Common Shares S - Sale D 11.3400 -547,430 -6,208 38,627,181
2025-05-08 2025-05-07 4 Ramaswamy Vivek ROIV Common Shares S - Sale D 11.1800 -625,000 -6,988 39,174,611
2025-05-08 2025-05-06 4 Ramaswamy Vivek ROIV Common Shares S - Sale D 11.4700 -273,959 -3,142 39,799,611
2025-01-27 2025-01-23 4 Ramaswamy Vivek Spousal ROIV Common Shares G - Gift I 13,357,857 13,357,857
2025-01-27 2025-01-23 4 Ramaswamy Vivek ROIV Common Shares G - Gift D -13,357,857 40,073,570
2024-04-12 3 Ramaswamy Vivek ROIV Common Shares D 53,431,426
2024-01-03 2024-01-02 4 Ramaswamy Vivek ROIV Common Shares S - Sale D 11.0500 -3,000,000 -33,150 51,929,426
2023-12-29 2023-12-27 4 Ramaswamy Vivek ROIV Common Shares F - Taxes D 11.5800 -133,911 -1,551 54,929,426
2023-12-29 2023-12-27 4 Ramaswamy Vivek ROIV Common Shares M - Exercise D 275,227 55,063,337
2023-09-29 2023-09-28 4 Ramaswamy Vivek ROIV Common Shares J - Other D 12.6700 -61,947 -785 54,788,110
2023-09-29 2023-09-27 4 Ramaswamy Vivek ROIV Common Shares M - Exercise D 119,534 54,850,057
2023-08-29 2023-08-28 4 Ramaswamy Vivek ROIV Common Shares J - Other D 11.2500 -47,692 -537 54,730,523
2023-08-29 2023-08-27 4 Ramaswamy Vivek ROIV Common Shares M - Exercise D 86,714 54,778,215
2023-08-01 2023-07-31 4 Ramaswamy Vivek ROIV Common Shares J - Other D 11.4300 -76,023 -869 54,691,501
2023-08-01 2023-07-27 4 Ramaswamy Vivek ROIV Common Shares M - Exercise D 166,057 54,767,524
2023-05-31 2023-05-31 4 Ramaswamy Vivek ROIV Common Shares J - Other D 9.0900 -189,947 -1,727 54,601,467
2023-05-31 2023-05-27 4 Ramaswamy Vivek ROIV Common Shares M - Exercise D 382,203 54,791,414
2023-02-22 2023-02-22 4 Ramaswamy Vivek ROIV Common Shares S - Sale D 7.9500 -4,000,000 -31,800 54,409,211
2021-10-01 3 Ramaswamy Vivek ROIV Common Shares D 58,409,211
P
السوق المفتوحة أو الشراء الخاص للأوراق المالية غير المشتقة أو المشتقة
S
السوق المفتوحة أو البيع الخاص للأوراق المالية غير المشتقة أو المشتقة
A
المنح أو المكافأة أو الاستحواذ على الأوراق المالية من الشركة (مثل الخيار)
C
تحويل المشتقات
D
بيع أو نقل الأوراق المالية مرة أخرى إلى الشركة
F
دفع سعر التمرين أو الالتزام الضريبي باستخدام جزء من الأوراق المالية المستلمة من الشركة
G
هدية الأوراق المالية من قبل أو إلى المطلعين
K
مقايضات الأسهم ومعاملات التحوط المماثلة
M
التمرين أو تحويل الأوراق المالية المشتقة المستلمة من الشركة (مثل الخيار)
V
معاملة تم الإبلاغ عنها طوعًا في النموذج 4
J
أخرى (مصحوبة بحاشية تصف المعاملة)